Debora Barton - 05 Jul 2022 Form 4 Insider Report for TScan Therapeutics, Inc. (TCRX)

Role
Chief Medical Officer
Signature
/s/ Debora Barton
Issuer symbol
TCRX
Transactions as of
05 Jul 2022
Net transactions value
$0
Form type
4
Filing time
07 Jul 2022, 07:57:10 UTC
Next filing
06 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRX Stock Option (right to buy) Award $0 +150,000 $0.000000 150,000 05 Jul 2022 Voting Common Stock 150,000 $3.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option will vest with respect to 25% of the shares after 12 months of continuous service to the Issuer following July 5, 2022, and the balance will vest in equal monthly installments over the next 36 months of continuous service to the Issuer.